SCHEMBL4151331

SCHEMBL4151331

Fc1ccccc1-c1cccc(CBr)c1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.48
DRD4 P21917 1/20 0.48
DRD3 P35462 1/20 0.48
FFAR1 O14842 3/20 0.46
SCN8A Q9UQD0 1/20 0.46
CASR P41180 1/20 0.45
HTR7 P34969 3/20 0.44
PTPRC P08575 1/20 0.43
PTPN1 P18031 1/20 0.43
MPO P05164 1/20 0.41
TRPA1 O75762 2/20 0.41
ALDH1A1 P00352 1/20 0.41
TSHR P16473 1/20 0.41
LIPG Q9Y5X9 1/20 0.41
VSIR Q9H7M9 1/20 0.40
ACMSD Q8TDX5 1/20 0.39
BACE1 P56817 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4303845 0.86 HTR7 (0.49) DRD2DRD4DRD3FFAR1SCN8A
SCHEMBL1373278 0.82 ALDH1A1 (0.52) HTR7TRPA1ALDH1A1TSHRBACE1
SCHEMBL4159809 0.82 CNR1 (0.42) HTR7ALDH1A1ACMSD
SCHEMBL3636690 0.81 SCN8A (0.49) DRD2DRD4DRD3FFAR1SCN8A
SCHEMBL7500105 0.81 DRD2 (0.48) DRD2DRD4DRD3FFAR1SCN8A
SCHEMBL5990056 0.81 HTR7 (0.51) DRD2DRD4DRD3FFAR1SCN8A
SCHEMBL29628986 0.80 PTPRC (0.55) DRD2DRD4DRD3FFAR1SCN8A
SCHEMBL12856837 0.80 PTPRC (0.55) DRD2DRD4DRD3FFAR1SCN8A
SCHEMBL1309108 0.79 TRPA1 (0.43) HTR7TRPA1ALDH1A1TSHR
SCHEMBL28268408 0.79 ALDH1A1 (0.54) HTR7TRPA1ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090105292-A9 Glucocorticoid Receptor Modulator Compounds and Methods LIGAND PHARMACEUTICALS INCORPORATED (US) 2009-04-23 US disclosed
US-20070281959-A1 Glucocorticoid receptor modulator compounds and methods LIGAND PHARMACEUTICALS INCORPORATED (US) 2007-12-06 US disclosed
EP-1718653-A1 GLUCOCORTICOID RECEPTOR MODULATOR COMPOUNDS AND METHODS- UTILITY Ligand Pharmaceuticals Inc. (US) 2006-11-08 EP disclosed
WO-2005082909-A1 GLUCOCORTICOID RECEPTOR MODULATOR COMPOUNDS AND METHODS- UTILITY LIGAND PHARMACEUTICALS INCORPORATED (US) 2005-09-09 WO disclosed
US-4536591-A Insecticidal [1,1'-biphenyl]-3-ylmethyl esters FMC CORPORATION (US) 1985-08-20 US disclosed
EP-0063374-B1 SUBSTITUTED BIPHENYL COMPOUNDS FMC Corporation (US) 1984-02-22 EP disclosed
US-4402973-A Insecticidal (1,1'-biphenyl)-3-ylmethyl esters FMC CORPORATION (US) 1983-09-06 US disclosed
EP-0020685-B1 INSECTICIDAL CYCLOPROPANECARBOXYLATES FROM SUBSTITUTED (1,1'-BIPHENYL)-3-YLMETHYL COMPOUNDS FMC Corporation (US) 1983-06-15 EP disclosed
EP-0063374-A1 Substituted biphenyl compounds FMC Corporation (US) 1982-10-27 EP disclosed
US-4329518-A INSECTICIDES, ACARICIDES, MITICIDES FMC CORPORATION (US) 1982-05-11 US disclosed
EP-0049977-A1 Insecticidal (1,1'-biphenyl)-3-ylmethyl esters, their production and use and compositions containing them FMC Corporation (US) 1982-04-21 EP disclosed
EP-0020685-A4 INSECTICIDAL CYCLOPROPANECARBOXYLATES FROM SUBSTITUTED (1,1'-BIPHENYL)-3-YLMETHYL COMPOUNDS. FMC CORP (US) 1981-07-16 EP disclosed
EP-0020685-A1 INSECTICIDAL CYCLOPROPANECARBOXYLATES FROM SUBSTITUTED (1,1'-BIPHENYL)-3-YLMETHYL COMPOUNDS. FMC CORP (US) 1981-01-07 EP disclosed
US-4214004-A MITICIDES FMC CORPORATION (US) 1980-07-22 US disclosed
WO-1980001163-A1 INSECTICIDAL CYCLOPROPANECARBOXYLATES FROM SUBSTITUTED(1,1'-BIPHENYL)-3-YLMETHYL COMPOUNDS FMC CORP (US) 1980-06-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105292-A9 Glucocorticoid Receptor Modulator Compounds and Methods NR3C1, NR3C2, MC2R DRD2 2477/4885DRD4 2903/4885DRD3 2662/4885
US-20070281959-A1 Glucocorticoid receptor modulator compounds and methods NR3C1, NR3C2, MC2R DRD2 2477/4885DRD4 2903/4885DRD3 2662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.